Computed tomographic findings in dogs with multiple myeloma

被引:2
作者
Hoim, Sven-Erik [1 ,5 ]
Fitzgerald, Ella [2 ]
Mapletoft, Emma [3 ]
Purzycka, Katarzyna [4 ]
机构
[1] Anderson Moores Vet Specialists Part Linnaeus Vet, Diagnost Imaging Dept, Poles Ln, Winchester, England
[2] ANTECH Imaging Serv, Fountain Valley, CA USA
[3] Queen Mother Hosp Anim, Royal Vet Coll, Diagnost Imaging Dept, N Mymms, Herts, England
[4] Lumbry Pk Vet Specialists, Oncol Dept, Alton, Hants, England
[5] Anderson Moores Vet Specialists Part Linnaeus Vet, Diagnost Imaging Dept, Poles Ln, Winchester SO21 2LL, England
关键词
computed tomography; dog; multiple myeloma; POSITRON-EMISSION-TOMOGRAPHY; BONE-DISEASE; MRI; RADIOGRAPHY; GAMMOPATHY; DIAGNOSIS; TUMORS; CT;
D O I
10.1002/vms3.1019
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
BackgroundComputed tomography (CT) is considered the first-line imaging modality for human patients with suspected multiple myeloma (MM). Recently the diagnostic criteria for human MM have been updated. ObjectivesTo describe and provide a baseline of the CT features and distribution of osseous lesions in dogs diagnosed with MM and to describe the change of initial osseous lesions after the start of treatment in a subset of dogs. MethodsSingle-centre, retrospective, descriptive, case series. Dogs were included when they met the updated MM criteria and if a staging CT was performed at the time of diagnosis and prior to initiation of treatment. When available, change of osseous lesions was assessed on serial imaging studies. ResultsThirteen dogs met the inclusion criteria. All dogs had involvement of the axial skeleton and 9/13 (69%) had concurrent involvement of the appendicular skeleton. Large (>= 1 cm), lytic, 'punched out' or expansile bony lesions and regions of permeative lysis were most common and mainly affected the vertebral column. Discrete intramedullary soft tissue attenuating lesions of the proximal appendicular skeleton were observed in 8/13 dogs (61%) and bilateral involvement of both humeri and femurs was seen in 4/9 dogs (44%). A subset of dogs underwent serial imaging and progressive replacement of the contrast-enhancing lesions with fat attenuating tissue was observed for all dogs, corresponding with clinical improvement. ConclusionsThis case series provides a baseline knowledge of the initial and follow-up CT features in dogs diagnosed with MM based on updated criteria.
引用
收藏
页码:660 / 669
页数:10
相关论文
共 38 条
  • [1] Role of MRI for the diagnosis and prognosis of multiple myeloma
    Baur-Melnyk, A
    Buhmann, S
    Dürr, HR
    Reiser, M
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2005, 55 (01) : 56 - 63
  • [2] Collins Conor D, 2004, Cancer Imaging, V4 Spec No A, pS47, DOI 10.1102/1470-7330.2004.0010
  • [3] Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma
    Dutoit, Julie C.
    Verstraete, Koenraad L.
    [J]. SKELETAL RADIOLOGY, 2017, 46 (06) : 733 - 750
  • [4] Ettinger J. S., 2016, TXB VET INTERNAL MED, P2076
  • [5] Detection of biclonal gammopathy by capillary zone electrophoresis in a cat and a dog with plasma cell neoplasia
    Facchini, Roberto Vailati
    Bertazzolo, Walter
    Zuliani, Davide
    Bonfanti, Ugo
    Caldin, Marco
    Avallone, Giancarlo
    Roccabianca, Paola
    [J]. VETERINARY CLINICAL PATHOLOGY, 2010, 39 (04) : 440 - 446
  • [6] Comparison of two melphalan protocols and evaluation of outcome and prognostic factors in multiple myeloma in dogs
    Fernandez, Ricardo
    Chon, Esther
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2018, 32 (03) : 1060 - 1069
  • [7] Multiple Myeloma: A Review of Imaging Features and Radiological Techniques
    Healy, C. F.
    Murray, J. G.
    Eustace, S. J.
    Madewell, J.
    O'Gorman, P. J.
    O'Sullivan, P.
    [J]. BONE MARROW RESEARCH, 2011,
  • [8] Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group
    Hillengass, J.
    Moulopoulos, L. A.
    Delorme, S.
    Koutoulidis, V.
    Mosebach, J.
    Hielscher, T.
    Drake, M.
    Rajkumar, S. V.
    Oestergaard, B.
    Abildgaard, N.
    Hinge, M.
    Plesner, T.
    Suehara, Y.
    Matsue, K.
    Withofs, N.
    Caers, J.
    Waage, A.
    Goldschmidt, H.
    Dimopoulos, M. A.
    Lentzsch, S.
    Durie, B.
    Terpos, E.
    [J]. BLOOD CANCER JOURNAL, 2017, 7 : e599 - e599
  • [9] International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
    Hillengass, Jens
    Usmani, Saad
    Rajkumar, S. Vincent
    Durie, Brian G. M.
    Mateos, Maria-Victoria
    Lonial, Sagar
    Joao, Cristina
    Anderson, Kenneth C.
    Garcia-Sanz, Ramon
    Riva Serra, Eloisa
    Du, Juan
    van de Donk, Niels
    Berdeja, Jesus G.
    Terpos, Evangelos
    Zamagni, Elena
    Kyle, Robert A.
    San Miguel, Jesus
    Goldschmidt, Hartmut
    Giralt, Sergio
    Kumar, Shaji
    Raje, Noopur
    Ludwig, Heinz
    Ocio, Enrique
    Schots, Rik
    Einsele, Hermann
    Schjesvold, Fredrik
    Chen, Wen-Ming
    Abildgaard, Niels
    Lipe, Brea C.
    Dytfeld, Dominik
    Wirk, Baldeep Mona
    Drake, Matthew
    Cavo, Michele
    Jose Lahuerta, Juan
    Lentzsch, Suzanne
    [J]. LANCET ONCOLOGY, 2019, 20 (06) : E302 - E312
  • [10] Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients
    Hinge, Maja
    Andersen, Kristian T.
    Lund, Thomas
    Jorgensen, Henrik B.
    Holdgaard, Paw C.
    Ormstrup, Tina E.
    Ostergaard, Lone L.
    Plesner, Torben
    [J]. HAEMATOLOGICA, 2016, 101 (10) : E415 - E418